Abstract:With the increasing aging of the population, the rational drug design for the treatment of Alzheimer's disease (AD) has become an important research area. Based on the multi-target design strategy, three coumarin derivatives 3a-3c were designed, synthesized and characterized by 1H NMR, 13C NMR and MS. The biological results showed that they had strong inhibition and high selectivity on acetylcholinesterase (AChE). Compound 3a had the strongest inhibitory effect on AChE (IC50 = 4.28 ± 0.22 μM). And all compounds could inhibit the self-induced and Cu2+-induced aggregation of β-amyloid (Aβ1-42), especially 3a had the best inhibitory effect on the self-aggregation of Aβ1-42 with the ratio of 64.27%. In addition, all compounds showed good antioxidant activity, which might be related to their hydroxyl groups. The compounds had good metal chelating ability, and could selectively chelate Cu2+, Al3+, Fe3+, Fe2+, and Zn2+ ions. Notably, the single crystals of 3b−Cu(II) complex [Cu2(C17H19N2O4)2Cl2]·2CH3OH were prepared and X-ray diffracted for the first time. X-ray crystallography analysis of 3b−Cu(II) complex provided a reliable structure-activity insight about the anti-oxidative and Aβ1-42 disaggregation activities. Furthermore, the results of docking study were consistent with the results of in vitro experiments. 3a-3c were predicted to have good blood brain barrier permeability and ADMET properties. Overall, 3a showed the best activity and might be a promising anti-AD agent.

Synthesis and Evaluation of 1,2,3,4-Tetrahydro-1-acridone Analogues As Potential Dual Inhibitors for Amyloid-Beta and Tau Aggregation.

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

Synthesis and Evaluation of Heterobivalent Tacrine Derivatives As Potential Multi-Functional Anti-Alzheimer Agents

Synthesis and Biological Evaluation of 5,6-Dihydro-benzo[c] Acridin-7-ol Derivatives As Anti-Alzheimers Disease Drugs

Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer’s disease

Design, Synthesis, and Biological Evaluation of 2-Arylethenylquinoline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Multitarget-directed Benzylideneindanone Derivatives: Anti-Β-amyloid (aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties Against Alzheimer's Disease.

Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease

Design, Synthesis and Evaluation of Isaindigotone Derivatives As Dual Inhibitors for Acetylcholinesterase and Amyloid Beta Aggregation

Synthesis, Biological Evaluation and Molecular Modeling of Benzofuran Piperidine Derivatives As Aβ Antiaggregant

Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer's disease agents.

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation

Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.

N-Benzyl, N-phenethyl and N-benzyloxybenzamide derivatives inhibit amyloid-beta (Aβ42) aggregation and mitigate Aβ42-induced neurotoxicity

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers As Potential Multitarget Agents for Alzheimer’s Disease

Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase

Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.

Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.